Factor VII

DBCAT000117Pharmacologic classB02BD05

Heat- and storage-stable plasma protein that is activated by tissue thromboplastin to form factor VIIa in the extrinsic pathway of blood coagulation. The activated form then catalyzes the activation of factor X to factor Xa. A DrugBank category of 3 drugs. 1 of them is approved.

ATC classification: B — BLOOD AND BLOOD FORMING ORGANS
B02 — ANTIHEMORRHAGICS
B02B — VITAMIN K AND OTHER HEMOSTATICS
B02BD — Blood coagulation factors
B02BD05 — coagulation factor VII
Also known as: Blood Coagulation Factor VII · Coagulation Factor VII · Factor VII, Coagulation · Factor, Stable · Proconvertin
Drugs: Coagulation factor VIIa Recombinant Human
Marzeptacog alfa (activated)
Vatreptacog alfa

What you can answer from here — as of August 24, 2016

3DrugsEach linked to its full drug card

Listed above

3Drug targetsEvery drug–target pair in the class, with bond type

61Marketed productsAcross the regions we cover, with dosage forms and routes

3Routes of administrationHow the drugs in this class are given

Which targets do Factor VII share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account